Literature DB >> 6165344

Chorioretinal and choriovitreal neovascularization. Their presence after photocoagulation of proliferative sickle cell retinopathy.

R V Dizon-Moore, L M Jampol, M F Goldberg.   

Abstract

Delayed development of choroidally fed neovascularization represents a potentially serious complication of feeder vessel photocoagulation of proliferative sickle cell retinopathy (PSR). Of the 53 photocoagulated eyes, choroidally fed neovascularization developed in 21 within one month to seven years (mean, 32.8 months). This complication appeared in eyes treated with argon laser and xenon arc. In 11, neovascular tissue remained flat in the chorioretinal scar (chorioretinal neovascularization), but in ten, the vessels grew into the vitreous (choriovitreal neovascularization). In many cases of chorioretinal neovascularization, the only subsequent complication was local vitreous hemorrhage. Visual acuities remained near normal. The development of choriovitreal neovascularization was associated with vitreous hemorrhages or retinal detachment in six of ten cases. Final visual acuities, however, were 20/50 or better in nine. Photocoagulation in some cases converted chorioretinal neovascularization to choriovitreal neovascularization or seemed to stimulate further growth of choriovitreal neovascularization. We now recommend no treatment for most cases of choroidally fed neovascularization. Photocoagulation techniques for PSR should attempt to minimize the development of choroidally fed neovascularization.

Entities:  

Mesh:

Year:  1981        PMID: 6165344     DOI: 10.1001/archopht.1981.03930010842011

Source DB:  PubMed          Journal:  Arch Ophthalmol        ISSN: 0003-9950


  7 in total

1.  Treatment of iatrogenic choriovitreal neovascularisation in sickle cell disease.

Authors:  R W Acheson; P D Fox; E L Chuang; G R Serjeant
Journal:  Br J Ophthalmol       Date:  1991-12       Impact factor: 4.638

2.  Iatrogenic choroidal neovascularisation following argon laser photocoagulation for choroidal malignant melanoma.

Authors:  Z I Currie; I G Rennie; J F Talbot
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  1996-04       Impact factor: 3.117

3.  Spontaneous peripheral chorioretinal neovascularisation in association with sickle cell anaemia.

Authors:  J C Liang; L M Jampol
Journal:  Br J Ophthalmol       Date:  1983-02       Impact factor: 4.638

4.  Outcome of iatrogenic choroidal neovascularisation in sickle cell disease.

Authors:  P D Fox; R W Acheson; G R Serjeant
Journal:  Br J Ophthalmol       Date:  1990-07       Impact factor: 4.638

5.  Idiopathic choriovitreal membrane--a case report.

Authors:  S H Sinclair; B D Salmenson
Journal:  Br J Ophthalmol       Date:  1992-09       Impact factor: 4.638

6.  Argon and krypton laser photocoagulation of senile exudative macular degeneration.

Authors:  J A Oosterhuis
Journal:  Doc Ophthalmol       Date:  1983-02-28       Impact factor: 2.379

Review 7.  Beyond the definitions of the phenotypic complications of sickle cell disease: an update on management.

Authors:  Samir K Ballas; Muge R Kesen; Morton F Goldberg; Gerard A Lutty; Carlton Dampier; Ifeyinwa Osunkwo; Winfred C Wang; Carolyn Hoppe; Ward Hagar; Deepika S Darbari; Punam Malik
Journal:  ScientificWorldJournal       Date:  2012-08-01
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.